Increasing focus on medical tourism improves MRI market prospects in Egypt, finds Frost & Sullivan
New analysis from Frost & Sullivan, Analysis of the Magnetic Resonance Imaging Market in Egypt, finds that the market earned revenues of $35 million in 2012 and estimates this to reach $66.7 million in 2019 at a compound annual growth rate (CAGR) of 9.4%. The research covers low-field, high-field, and ultra-high-field MRI systems.
“Egypt has a high concentration of private radiology practices that utilise latest technology and high-end MRI equipment as a strategy to stay ahead of the competition,” says Frost & Sullivan Healthcare Research Analyst Kudzai Moyo. “The use of high-field systems, in particular, will increase owing to their ability to facilitate multiple, non-invasive examinations and generate large amounts of information.”
The focus on medical tourism will further encourage private healthcare institutions in the country to adopt large-scale, high-end clinical care. Private hospitals are looking to upgrade their radiology facilities to offer highly efficient and reliable healthcare services, allowing them to compete with other countries in the region, whilst expanding market potential.
Current MRI market revenues are however low, as several private hospitals await the political transition in Egypt before proceeding with their investments. Similarly, uptake in the public sector is likely to be subdued in the short-to-medium term, as the state budget for healthcare remains limited. Nevertheless, the long-term impact of this restraint will reduce as pressure groups advocate for a budget increase.
“In this competitive landscape, forming alliances with government entities and private businesses will assist MRI equipment manufacturers to secure healthcare project contracts in Egypt,” reveals Frost & Sullivan Healthcare Research Analyst Shalena Naidoo. “Partnerships will also enable the standardisation of medical imaging modalities, which is a key criteria for end users.”
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.